We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Abbott Laboratories | NYSE:ABT | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.46 | 0.43% | 106.38 | 106.615 | 105.92 | 106.40 | 205,587 | 14:48:06 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
WHITE MILES D |
2. Issuer Name
and
Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chairman and CEO |
100 ABBOTT PARK ROAD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
ABBOTT PARK, IL 60064-6400 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common shares without par value | 12/6/2017 | S | 4702 | D | $54.76 | 3225385 | D | |||
Common shares without par value | 12/6/2017 | S | 398 | D | $54.765 | 3224987 | D | |||
Common shares without par value | 12/6/2017 | S | 4439 | D | $54.77 | 3220548 | D | |||
Common shares without par value | 12/6/2017 | S | 1097 | D | $54.775 | 3219451 | D | |||
Common shares without par value | 12/6/2017 | S | 3898 | D | $54.78 | 3215553 | D | |||
Common shares without par value | 12/6/2017 | S | 1400 | D | $54.785 | 3214153 | D | |||
Common shares without par value | 12/6/2017 | S | 2300 | D | $54.79 | 3211853 | D | |||
Common shares without par value | 12/6/2017 | S | 1200 | D | $54.795 | 3210653 | D | |||
Common shares without par value | 12/6/2017 | S | 5600 | D | $54.80 | 3205053 | D | |||
Common shares without par value | 12/6/2017 | S | 398 | D | $54.805 | 3204655 | D | |||
Common shares without par value | 12/6/2017 | S | 6200 | D | $54.81 | 3198455 | D | |||
Common shares without par value | 12/6/2017 | S | 1602 | D | $54.815 | 3196853 | D | |||
Common shares without par value | 12/6/2017 | S | 4500 | D | $54.82 | 3192353 | D | |||
Common shares without par value | 12/6/2017 | S | 200 | D | $54.825 | 3192153 | D | |||
Common shares without par value | 12/6/2017 | S | 2403 | D | $54.83 | 3189750 | D | |||
Common shares without par value | 12/6/2017 | S | 1000 | D | $54.835 | 3188750 | D | |||
Common shares without par value | 12/6/2017 | S | 4297 | D | $54.84 | 3184453 | D | |||
Common shares without par value | 12/6/2017 | S | 2359 | D | $54.845 | 3182094 | D | |||
Common shares without par value | 12/6/2017 | S | 6975 | D | $54.85 | 3175119 | D | |||
Common shares without par value | 12/6/2017 | S | 144 | D | $54.855 | 3174975 | D | |||
Common shares without par value | 12/6/2017 | S | 2500 | D | $54.86 | 3172475 | D | |||
Common shares without par value | 12/6/2017 | S | 197 | D | $54.865 | 3172278 | D | |||
Common shares without par value | 12/6/2017 | S | 3897 | D | $54.87 | 3168381 | D | |||
Common shares without par value | 12/6/2017 | S | 100 | D | $54.875 | 3168281 | D | |||
Common shares without par value | 12/6/2017 | S | 3103 | D | $54.88 | 3165178 | D | |||
Common shares without par value | 12/6/2017 | S | 1500 | D | $54.89 | 3163678 | D | |||
Common shares without par value | 12/6/2017 | S | 499 | D | $54.895 | 3163179 | D | |||
Common shares without par value | 12/6/2017 | S | 1618 | D | $54.90 | 3161561 | D | |||
Common shares without par value | 12/6/2017 | S | 797 | D | $54.905 | 3160764 | D | |||
Common shares without par value | 12/6/2017 | S | 2207 | D | $54.91 | 3158557 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
Remarks:
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 4 of 5. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
WHITE MILES D
100 ABBOTT PARK ROAD ABBOTT PARK, IL 60064-6400 |
X |
|
Chairman and CEO |
|
Signatures
|
||
John A. Berry, by power of attorney for Miles D. White | 12/8/2017 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Abbott Laboratories Chart |
1 Month Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions